在医保支付改革推动下,药品院内外渠道正发生深刻变革。院内渠道因集采等改革,优化用药结构、降低采购成本;院外渠道借门诊统筹、双通道药房等政策迎来新机遇。医药魔方最新发布《2025Q1中国药品市场销售分析报告》,其数据来源于PharmaBI®IPM中国药品销售库,旨在通过专业分析及基础数据支持,解析院内外渠道销售格局的影响,为洞察市场提供依据。本文提炼报告核心数据与趋势,为行业从业者提供关键洞察,点击...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.